Bluejay Diagnostics, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
NorthStrive Fund II LP and Manager Braeden Lichti have liquidated their entire stake in Bluejay Diagnostics, Inc., marking a complete exit from the company.
NASDAQ
Braeden Lichti and Northstrive Fund II LP have filed an exit notice confirming the sale of their entire stake in Bluejay Diagnostics, Inc.